Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Amy W. Schulman currently holds 2,750 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy W. Schulman has been a net buyer of ALNY stock. They have purchased $14.2M and sold $9.9M worth of shares.
Amy W. Schulman's most recent insider trade was on Jun 25, 2024, when they sold 8,500 shares at $0.00 per share.
Amy W. Schulman serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 69 insider transactions totaling $24.1M over their tenure at the company.
Amy W. Schulman holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Amy W. Schulman has shown a buying trading pattern, with $14.2M in total purchases and $9.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Amy W. Schulman was on Apr 8, 2019, when they purchased $9.7M worth of CYCN shares. This transaction involved 604,482 shares at $16.00 per share.
Amy W. Schulman currently owns 2,750 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Amy W. Schulman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Amy W. Schulman has 69 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Amy W. Schulman and 40,000+ other insiders.